Cyclic GMP contents of the thyroid gland and ovary were significantly increased in response to single and multiple treatments of bromocriptine, an effect which was antagonized by sulpiride. Liver and adrenocortical cyclic GMP levels have not been changed by bromocriptine although sulpiride alone induced a significant reduction. The data may indicate the presence of D2 receptors in ovary and thyroid gland that are related to cyclic GMP.

Keywords:
bromocriptine, cyclic GMP, endocrine glands, liver
This content is only available as a PDF.
© 1987 Plenum Publishing Corporation
1987
You do not currently have access to this content.